In general, more than half of all people with CHF survive for 5 years after diagnosis, according to a 2019 systematic review and meta‐analysisTrusted Source .

27 мар. 2024 г. · And life expectancy is on the rise: Roughly half of people diagnosed today can expect to live at least 5 more years, compared with 41% in 2000, ...

The average life-span of the cohort was 5.5 years (STD +/− 10.0) ranging from 19.5 years for low-risk women of less than 50 years old to 2.9 years for high-risk ...

The overall mortality rate was 34% at 1 year, 59% at 2 years, and 76% at 3 years. The mortality rate in patients with coronary artery disease was 46 and 69% at ...

One study of patients with dilated cardiomyopathy treated with heart transplantation had survival rates of 91% at 1 year, 80% at 5 years, and 50% at 20 years.

30 янв. 2024 г. · The survival rate of a person with CHF depends on how the well the heart functions, their age and CHF stage, whether they have other diseases, and more.

At a population level, epidemiological evidence shows mean survival rates in chronic HF of 80–90%, 50–60%, and 30% at 1, 5, and 10 years respectively. However, ...

14 янв. 2021 г. · Initial cohorts of LVNC suggested 35% to 38% mortality over median 5 to 11 years of follow‐up., Our data suggest that LVNC prognosis is overall ...

The 5-year survival rate of the general population was 93%, compared with 69% of those with LVSD without HF, 62% with HF and no LVSD, and 53% with HF plus LVSD.

The majority of patients with hypertrophic cardiomyopathy have no symptoms and most have a near-normal life expectancy. What Is It? · Symptoms · Diagnosis · Treatment